Amylosulfuric Acid

Amylosulfuric Acid

SCHEMBL9950149

CCCCCOS(=O)(=O)[O-].CCCCCOS(=O)(=O)[O-].[Mg+2]

nearest known ligand 0.87

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ATP4AATP4BGABBR1GABBR2HMGCR

The experimentally established mechanism targets of Amylosulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 2/20 0.87
TSHR P16473 2/20 0.87
GLA P06280 1/20 0.87
HPGD P15428 1/20 0.87
MAPK1 P28482 1/20 0.87
EPHX2 P34913 1/20 0.87
BLM P54132 1/20 0.87
CA1 P00915 12/20 0.58
CA2 P00918 12/20 0.58
CA9 Q16790 10/20 0.58
CA12 O43570 3/20 0.56
CA7 P43166 3/20 0.56
CA14 Q9ULX7 3/20 0.56
CA3 P07451 2/20 0.56
CA4 P22748 2/20 0.56
CA6 P23280 2/20 0.56
CA5A P35218 2/20 0.56
CA5B Q9Y2D0 2/20 0.56
KDM4E B2RXH2 1/20 0.44
USP2 O75604 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8371870 0.98 RECQL (0.91) RECQLTSHRGLAHPGDMAPK1
SCHEMBL430295 0.98 RECQL (0.91) RECQLTSHRGLAHPGDMAPK1
SCHEMBL27193 0.98 RECQL (0.91) RECQLTSHRGLAHPGDMAPK1
Octadecyl Sulfate SCHEMBL29135085 0.98 RECQL (0.91) RECQLTSHRGLAHPGDMAPK1
SCHEMBL18335522 0.98 RECQL (0.91) RECQLTSHRGLAHPGDMAPK1
SCHEMBL3196439 0.98 RECQL (0.91) RECQLTSHRGLAHPGDMAPK1
SCHEMBL6536390 0.98 RECQL (0.91) RECQLTSHRGLAHPGDMAPK1
SCHEMBL10768370 0.98 RECQL (0.91) RECQLTSHRGLAHPGDMAPK1
SCHEMBL10768334 0.98 RECQL (0.91) RECQLTSHRGLAHPGDMAPK1
SCHEMBL1537676 0.96 RECQL (0.96) RECQLTSHRGLAHPGDMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120165329-A1 COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR PLEXXIKON INC 2012-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120165329-A1 COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR PRKDC, PRKACA, PRKACG RECQL 3012/4885TSHR 2257/4885GLA 895/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.